1. Home
  2. SPRO vs DSWL Comparison

SPRO vs DSWL Comparison

Compare SPRO & DSWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRO
  • DSWL
  • Stock Information
  • Founded
  • SPRO 2013
  • DSWL 1987
  • Country
  • SPRO United States
  • DSWL Macau
  • Employees
  • SPRO N/A
  • DSWL N/A
  • Industry
  • SPRO Biotechnology: Pharmaceutical Preparations
  • DSWL Plastic Products
  • Sector
  • SPRO Health Care
  • DSWL Industrials
  • Exchange
  • SPRO Nasdaq
  • DSWL Nasdaq
  • Market Cap
  • SPRO 33.0M
  • DSWL 37.8M
  • IPO Year
  • SPRO 2017
  • DSWL 1995
  • Fundamental
  • Price
  • SPRO $2.50
  • DSWL $2.30
  • Analyst Decision
  • SPRO Buy
  • DSWL
  • Analyst Count
  • SPRO 4
  • DSWL 0
  • Target Price
  • SPRO $5.00
  • DSWL N/A
  • AVG Volume (30 Days)
  • SPRO 10.8M
  • DSWL 26.0K
  • Earning Date
  • SPRO 05-13-2025
  • DSWL 06-20-2025
  • Dividend Yield
  • SPRO N/A
  • DSWL 8.70%
  • EPS Growth
  • SPRO N/A
  • DSWL 69.42
  • EPS
  • SPRO N/A
  • DSWL 0.65
  • Revenue
  • SPRO $44,584,000.00
  • DSWL $66,813,999.00
  • Revenue This Year
  • SPRO N/A
  • DSWL N/A
  • Revenue Next Year
  • SPRO N/A
  • DSWL N/A
  • P/E Ratio
  • SPRO N/A
  • DSWL $3.55
  • Revenue Growth
  • SPRO N/A
  • DSWL N/A
  • 52 Week Low
  • SPRO $0.51
  • DSWL $1.93
  • 52 Week High
  • SPRO $2.80
  • DSWL $2.74
  • Technical
  • Relative Strength Index (RSI)
  • SPRO 86.18
  • DSWL 47.82
  • Support Level
  • SPRO $0.66
  • DSWL $1.93
  • Resistance Level
  • SPRO $2.48
  • DSWL $2.45
  • Average True Range (ATR)
  • SPRO 0.13
  • DSWL 0.11
  • MACD
  • SPRO 0.20
  • DSWL -0.00
  • Stochastic Oscillator
  • SPRO 86.36
  • DSWL 67.27

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

About DSWL Deswell Industries Inc.

Deswell Industries Inc is engaged in the manufacturing and selling of injection-molded plastic parts and components. In addition, it also offers manufacturing services for electronic products and subassemblies and manufactures metallic molds and accessory parts for original equipment manufacturers and contract manufacturers. The company conducts all of its manufacturing activities at separate plastics, electronics and metallic operation factories located in the People's Republic of China. It operates through the Plastic Injection Molding and Electronic Products Assembling segments. The firm offers products such as automobile components, medical testing equipment, parts for audio equipment, av receivers, active subwoofers, digital system key sets, communication products and others.

Share on Social Networks: